Christopher D. Lao

37.8k citations
121 papers · 8.5k · 4 hit papers · h-index 38

Impact in

    • Curcumin's Biomedical Applications
  • Oncology top 0.2%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cutaneous Melanoma Detection and Management

Papers in

    • Cancer Immunotherapy and Biomarkers 61
    • CAR-T cell therapy research 43
    • Cutaneous Melanoma Detection and Management 15
    • Polyomavirus and related diseases 6
    • Melanoma and MAPK Pathways 42

Christopher D. Lao

117 papers receiving 8.3k citations

Christopher D. Lao's Hit Papers

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression 2018 · 455 citations
4550+6+13Years since publication2505007501000

Peers

Christopher D. Lao
Comparison fields: 5 of 127
  • Molecular Medicine 904
  • Oncology 4.0k
  • Immunology 2.8k
  • Molecular Biology 1.9k
  • Dermatology 234
Replace Paul R. Thompson with:
Paul R. Thompson United States
Spiridione Garbisa Italy
C. Richard Boland United States
Shrikant Anant United States
Shi H China
G Steiner Austria
Judith E. Karp United States
Gregory B. Lesinski United States
Hamid Reza Mirzaei Iran
Hirohisa Yano Japan
Christopher D. Lao relative to Paul R. Thompson United States Paul R. Thompson's profile →
Citations per field
00.5×4.7×
Paul R. Thompson · 1×
Citations per year

Countries citing papers authored by Christopher D. Lao

Since Specialization
Citations

This map shows the geographic impact of Christopher D. Lao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Lao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Lao more than expected).

Fields of papers citing papers by Christopher D. Lao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Lao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Lao. The network helps show where Christopher D. Lao may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher D. Lao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher D. Lao Line = papers co-authored together Christopher D. Lao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dose escalation of a curcuminoid formulation
Hit paper breakdown →
20061144
2
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
Hit paper breakdown →
20181033
3
ICOS Receptor Instructs T Follicular Helper Cell versus Effector Cell Differentiation via Induction of the Transcriptional Repressor Bcl6
Hit paper breakdown →
2011741
4
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
Hit paper breakdown →
2018455
5 2011426
6 2017313
7 2017285
8 2013248
9 2007243
10 2013235
11 2017207
12 2016177
13 2015172
14 2012131
15 2021120
16 2011114
17 2019113
18
Surveillance for foodborne-disease outbreaks--United States, 1988-1992.
1996110
19 2021103
20 201796

About Christopher D. Lao

Christopher D. Lao is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Organic Chemistry, having authored 121 papers that have together received 8.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (61 papers), CAR-T cell therapy research (43 papers), Melanoma and MAPK Pathways (42 papers), Cutaneous Melanoma Detection and Management (15 papers), Immunotherapy and Immune Responses (14 papers), Brain Metastases and Treatment (11 papers), Polyomavirus and related diseases (6 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Molecular Medicine (904 citations), Oncology (4.0k citations), Immunology (2.8k citations), Molecular Biology (1.9k citations) and Dermatology (234 citations). Christopher D. Lao has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Shane Crotty, Danelle S. Eto, Dirk Schadendorf, Robin Kageyama, Youn Soo Choi, F. Stephen Hodi, James Larkin, Dean E. Brenner, Jedd D. Wolchok and Daniel P. Normolle. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal for ImmunoTherapy of Cancer, Cancer and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact